Stocks · Health care · Pharmaceutical Preparations

ACADIA PHARMACEUTICALS INC

ACAD Clue Score69

United States Fiscal year ends December CIK 0001070494 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net buying

Individual transactions

Insider

Date

Role

Action

Price

Amount

Baker Bros. Advisors LP

23 May 2023

Director

Exercised, kept indirect

12,500

$17.01

$212.63K

Baker Bros. Advisors LP

23 May 2023

Director

Exercised, kept indirect

12,500

$17.01

$212.63K

Baker Bros. Advisors LP

12 Jan 2023

Director

Exercised, kept indirect

15,000

$5.22

$78.30K

Baker Bros. Advisors LP

12 Jan 2023

Director

Exercised, kept indirect

15,000

$5.22

$78.30K

Showing 250 of 275 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 324

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 19

Sales on a Rule 10b5-1 plan 12

Sales straight out of an exercise 89

Sales at will 107

Transactions with no price 0

Shares from compensation/vesting 6,108,828

Sales filed before the plan box existed 36

History held since 13 Dec 2006